TEVA

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Dollar change -0.16
Percentage change -0.92	%

Peers: ABBV AZN BMY GSK JNJ LLY MRK NVS PFE SNY

| Held by: IEFA EFA EFV PPH IXUS SPDW EIS IDEV IVLU GSIE

Index	-	P/E	-	EPS (ttm)	-0.39	Insider Own	0.01%	Shs Outstand	1.13B	Perf Week	-1.37%
Market Cap	19.54B	Forward P/E	6.20	EPS next Y	2.78	Insider Trans	-86.64%	Shs Float	1.13B	Perf Month	-4.22%
Income	-444.00M	PEG	-	EPS next Q	0.66	Inst Own	54.46%	Short Float	2.16%	Perf Quarter	1.00%
Sales	16.30B	P/S	1.20	EPS this Y	-4.46%	Inst Trans	3.32%	Short Ratio	3.08	Perf Half Y	29.70%
Book/sh	5.61	P/B	3.07	EPS next Y	13.75%	ROA	-1.05%	Short Interest	24.49M	Perf Year	90.82%
Cash/sh	1.99	P/C	8.66	EPS next 5Y	0.59%	ROE	-6.61%	52W Range	8.06 - 19.08	Perf YTD	65.23%
Dividend Est.	-	P/FCF	9.42	EPS past 5Y	26.63%	ROI	-1.91%	52W High	-9.59%	Beta	0.87
Dividend TTM	-	Quick Ratio	0.59	Sales past 5Y	-2.68%	Gross Margin	49.52%	52W Low	114.15%	ATR (14)	0.41
Dividend Ex-Date	Nov 27, 2017	Current Ratio	0.89	EPS Y/Y TTM	80.64%	Oper. Margin	21.54%	RSI (14)	43.30	Volatility	1.97% 2.10%
Employees	37226	Debt/Eq	2.98	Sales Y/Y TTM	8.38%	Profit Margin	-2.72%	Recom	1.75	Target Price	22.14
Option/Short	Yes / Yes	LT Debt/Eq	2.65	EPS Q/Q	3.09%	Payout	-	Rel Volume	0.85	Prev Close	17.41
Sales Surprise	2.68%	EPS Surprise	10.51%	Sales Q/Q	7.21%	Earnings	Nov 06 BMO	Avg Volume	7.94M	Price	17.25
SMA20	-2.10%	SMA50	-3.31%	SMA200	13.19%	Trades		Volume	6,763,731	Change	-0.92%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-10-24	Upgrade	Argus	Hold → Buy	$20
Mar-08-24	Upgrade	JP Morgan	Underweight → Neutral	$14
Feb-12-24	Upgrade	Piper Sandler	Neutral → Overweight	$12 → $19
Jan-23-24	Upgrade	Jefferies	Hold → Buy	$10 → $14
Jan-03-24	Upgrade	Piper Sandler	Underweight → Neutral	$8 → $12
Dec-18-23	Initiated	HSBC Securities	Buy	$13
Nov-27-23	Upgrade	UBS	Neutral → Buy	$11 → $13
Jul-06-23	Upgrade	UBS	Sell → Neutral	$7 → $8
May-25-23	Initiated	Morgan Stanley	Equal-Weight	$10
May-18-23	Upgrade	Evercore ISI	In-line → Outperform
Jan-19-23	Downgrade	Jefferies	Buy → Hold	$10 → $12
Nov-14-22	Downgrade	JP Morgan	Neutral → Underweight	$11 → $10
Nov-04-22	Downgrade	UBS	Neutral → Sell
Oct-21-22	Resumed	Jefferies	Buy	$10
Aug-05-22	Upgrade	BofA Securities	Neutral → Buy	$10 → $13
Jun-14-22	Resumed	UBS	Neutral	$10
May-17-22	Upgrade	BofA Securities	Underperform → Neutral	$9
May-04-22	Downgrade	Piper Sandler	Neutral → Underweight	$11 → $7
Apr-05-22	Upgrade	Barclays	Equal Weight → Overweight	$11 → $13
Mar-25-22	Upgrade	Bernstein	Mkt Perform → Outperform	$11

Show Previous Ratings

Oct-11-24 12:49PM	Teva Pays $450M To Resolve Alleged Kickback, Price-Fixing Schemes (Benzinga)
Oct-10-24 05:19PM	Teva Pharmaceuticals to Pay $450 Million to Settle Kickback Allegations (The Wall Street Journal)
Oct-09-24 03:30PM	Teva Pharmaceutical Industries Ltd (TEVA) Q2 2024 Earnings Call Highlights: Strong Revenue ... (GuruFocus.com)
Oct-08-24 07:00AM	Teva Prolia (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA (GlobeNewswire)
Oct-07-24 09:40AM	Are Investors Undervaluing Teva Pharmaceutical Industries (TEVA) Right Now? (Zacks)
09:40AM	Loading…
09:40AM	Is Teva Pharmaceutical Industries (TEVA) Stock Outpacing Its Medical Peers This Year? (Zacks)
Oct-04-24 06:33AM	Teva and mAbxience partner to develop biosimilar candidate for oncology (Pharmaceutical Technology)
Oct-03-24 08:30AM	Teva and mAbxience Expand Strategic Partnership to include an additional Oncology Biosimilar Candidate (GlobeNewswire)
Oct-01-24 08:29AM	Teva Announces Launch of the First and Only Generic Version of Sandostatin LAR Depot (octreotide acetate for injectable suspension), in the U.S. (GlobeNewswire)
03:38AM	Why Are Analysts Bullish On Teva Pharmaceutical Industries Limited (TEVA) Right Now? (Insider Monkey)
Sep-30-24 04:30PM	Teva to Host Conference Call to Discuss Third Quarter 2024 Financial Results at 8 a.m. ET on November 6, 2024 (GlobeNewswire)
01:01PM	Invesco EQV European Equity Fund Bolsters Position in Teva Pharmaceutical with a 1. ... (GuruFocus.com)
Sep-24-24 08:45AM	As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse (GlobeNewswire)
Sep-23-24 10:33AM	Teva touts safety profile of once monthly schizophrenia therapy (Pharmaceutical Technology)
01:00AM	Teva Announces Long Term Efficacy and Safety of Deutetrabenazine in European Patients with Debilitating Movement Disorder Tardive Dyskinesia (GlobeNewswire)
04:15AM	Loading…
Sep-21-24 04:15AM	Teva Presents New Phase 3 Efficacy, Safety and Tolerability Data from SOLARIS Trial Evaluating TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable for Adult Patients Diagnosed with Schizophrenia (GlobeNewswire)
04:10AM	New Data Provide Treatment Insights into Options for Switching Adult Patients Diagnosed with Schizophrenia to UZEDY (risperidone) Extended-Release Injectable Suspension from Perseris (RBP-7000) (GlobeNewswire)
Sep-11-24 04:30PM	Teva to Present at the Bank of America 2024 Global Healthcare Conference (GlobeNewswire)
Sep-10-24 04:23PM	Baltimore settles with Teva, Walgreens ahead of scheduled opioid trial (Reuters)
03:34PM	Teva agrees to pay Baltimore City $80m for fuelling opioid epidemic (Pharmaceutical Technology)
Sep-06-24 01:46PM	JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability (Benzinga)
Aug-27-24 01:01PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
Aug-26-24 05:00PM	Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (GlobeNewswire)
Aug-02-24 02:22PM	What Are the Hottest Biotech Stocks Right Now? 3 Top Picks. (InvestorPlace)
Jul-31-24 04:13PM	Teva Pharma, With A 67% Gain This Year, Flirts With A Breakout On Beat-And-Raise Report (Investor's Business Daily) +6.22%
02:11PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
12:00PM	Teva Pharmaceutical Industries (TEVA) Q2 2024 Earnings Call Transcript (Motley Fool)
10:00AM	Teva Pharmaceutical Industries (TEVA) Reports Q2 Earnings: What Key Metrics Have to Say (Zacks)
09:42AM	Teva Pharma Flirts With Breakout As Generic Drugs Drive Beat-And-Raise (Investor's Business Daily)
09:40AM	Is Teva Pharmaceutical Industries (TEVA) Stock Undervalued Right Now? (Zacks)
07:00AM	Loading…
07:00AM	Teva Announces Strong Growth in Second Quarter Revenues mainly driven by Generics Products in All Regions and AUSTEDO ; Raises 2024 Financial Guidance (GlobeNewswire)
Jul-29-24 09:16AM	Unveiling Teva Pharmaceutical Industries (TEVA) Q2 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Jul-25-24 01:30AM	Teva and Sanofi Announce Accelerated Timeline for Anti-TL1A Phase 2b Program in Patients with Inflammatory Bowel Disease (Business Wire)
Jul-19-24 05:12AM	Teva reports positive data from Phase III paediatric migraine prevention trial (Clinical Trials Arena)
Jul-18-24 08:30AM	Teva Announces First Phase 3 Evidence of Efficacy and Safety of an Anti-CGRP Monoclonal Antibody in Children in AJOVY (fremanezumab) SPACE Trial for Prevention of Episodic Migraine (Business Wire)
Jul-17-24 05:21AM	3 No-Brainer Stocks to Buy With $200 Right Now (Motley Fool)
Jul-12-24 08:22PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
Jul-09-24 08:22PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research) +7.40%
Jul-02-24 06:00PM	Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024 (Business Wire)
01:33PM	FTC investigates Teva over contested product patents (Pharmaceutical Technology)
Jun-28-24 11:30AM	New AJOVY (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses (Business Wire)
Jun-25-24 08:00AM	Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020 (Business Wire)
Jun-24-24 04:54PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
09:50AM	Teva Announces Launch of Authorized Generic of Victoza (liraglutide injection 1.8mg), in the United States (Business Wire)
Jun-22-24 09:03AM	Did Teva Pharmaceutical Industries Limited (TEVA)'s Pivot to Growth Strategy Help It Get a Positive Rating from Analysts? (Insider Monkey)
Jun-21-24 01:06PM	10 Best Robinhood Stocks Under $20 (Insider Monkey)
Jun-14-24 07:15AM	7 A-Rated Biotech Stocks Worth Betting on in June (InvestorPlace)
Jun-13-24 05:35PM	Teva sues Corcept over mifepristone 'monopoly' for rare disorder (Reuters)
Jun-11-24 08:20PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
Jun-04-24 04:05PM	Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference (Business Wire)
Jun-01-24 02:25PM	New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY (risperidone) Extended-Release Injectable Suspension from Invega Sustenna (paliperidone palmitate) (Business Wire)
02:20PM	Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024 (Business Wire)
May-30-24 06:35AM	FDA approves Teva Pharmaceuticals AUSTEDO XR for TD and HD chorea (Pharmaceutical Technology)
May-29-24 06:38PM	Teva Announces AUSTEDO XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (2448 mg/day) (Business Wire)
May-24-24 08:11PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research)
May-20-24 08:25PM	Teva and Alvotech Announce SIMLANDI (adalimumab-ryvk) Injection Now Available in the U.S. (Business Wire)
May-17-24 11:00AM	Insider Sale: Chief Accounting Officer Amir Weiss Sells 28,135 Shares of Teva Pharmaceutical ... (GuruFocus.com)
09:06AM	Teva Pharmaceutical Industries Insider Sold Shares Worth $470,794, According to a Recent SEC Filing (MT Newswires)
May-16-24 06:15AM	Patent Peril: 3 Stocks at Risk From the FTC's Drug Crusade (InvestorPlace)
May-15-24 09:12AM	Teva Pharmaceutical Industries Insider Sold Shares Worth $254,807, According to a Recent SEC Filing (MT Newswires)
08:15AM	Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations (Business Wire)
May-14-24 07:00AM	Israels Once-Dominant Drugmaker Is Revived by Innovation (The Wall Street Journal)
May-13-24 09:40AM	Piper Sandler Adjusts Price Target on Teva Pharmaceutical Industries to $20 From $19, Maintains Overweight Rating (MT Newswires)
09:40AM	Should Value Investors Buy Teva Pharmaceutical Industries (TEVA) Stock? (Zacks)
May-09-24 11:37AM	Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript (Insider Monkey)
09:33AM	Affirm stock sinking, Good Buy or Goodbye: Market Domination (Yahoo Finance Video)
06:22AM	Teva and Medincell report positive data for TEV-749 in schizophrenia trial (Clinical Trials Arena)
May-08-24 04:29PM	Analyst Report: Teva Pharmaceutical Industries Limited (Morningstar Research) +12.83%
04:02PM	Teva Pharma's Turnaround Story: How A Key Win Helped It Clinch A Five-Year High (Investor's Business Daily)
02:10PM	Teva Stock Powers Ahead as Schizophrenia News Offsets Mixed Earnings (Barrons.com)
02:00PM	Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript (Motley Fool)
12:51PM	Update: Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed (MT Newswires)
11:56AM	TEVA Stock Earnings: Teva Pharmaceutical Indus Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace)
10:47AM	Teva Pharma Shoots To 5-Year High With Good News For Its Blockbuster Hopeful (Investor's Business Daily)
09:42AM	Teva Stock Is Powering Ahead as Schizophrenia News Offsets Mixed Earnings (Barrons.com)
09:30AM	Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
09:18AM	Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday (MT Newswires)
08:53AM	Sector Update: Health Care (MT Newswires)
08:53AM	Teva Surges To 5-Year High On Maintained Outlook Despite Mixed First Quarter (Investor's Business Daily)
07:58AM	Teva Pharmaceutical Industries Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed (MT Newswires)
07:55AM	REFILE-UPDATE 1-Teva Pharm Q1 profit misses estimates, revenue rises (Reuters)
07:28AM	Teva Pharmaceutical Industries Posts Narrower Loss In Q1 - Update (RTT News)
07:20AM	Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates (Reuters)
07:19AM	Teva Pharm Q1 profit falls short of estimates, revenue gains (Reuters)
07:00AM	Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook (Business Wire)
06:56AM	UPDATE 1-Teva and Medincell's schizophrenia drug meets main goal of late-stage study (Reuters)
06:36AM	Teva and Medincell's schizophrenia drug meets main goal of late-stage study (Reuters)
06:30AM	Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia (Business Wire)
May-07-24 04:30PM	Teva Earnings Are Soon. What Could Keep the Stock Gains Going. (Barrons.com)
12:45PM	20 States with the Highest Fertility Rates in the US (Insider Monkey)
May-03-24 05:58PM	A Week Of Fast-Moving Stocks Ahead: Disney, Toyota, Ferrari, Constellation (Investor's Business Daily)
09:15AM	Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for Key Metrics (Zacks)
May-02-24 06:30PM	Teva to Present at the 2024 Bank of America Healthcare Conference (Business Wire)
10:48AM	Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2024 Earnings Call Transcript (Insider Monkey)
08:30AM	Tevas 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets (Business Wire)
08:01AM	Q1 2024 Corcept Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
03:41AM	Corcept Therapeutics Inc (CORT) Q1 2024 Earnings Call Transcript Highlights: Strong Growth Amid ... (GuruFocus.com)
Apr-30-24 11:32AM	Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals (MT Newswires)
04:00AM	U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira (adalimumab) (Business Wire)
Apr-22-24 11:37AM	UPDATE 1-U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents (Reuters)

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Daniell Richard	Exec. VP, European Commercial	Aug 12 '24	Sale	17.30	98,943	1,711,447	0	Aug 13 04:09 PM
Grant Angus	EVP, Business Development	Aug 09 '24	Sale	17.28	4,065	70,243	8,848	Aug 13 04:06 PM
Hughes Eric A	See "Remarks"	Aug 09 '24	Sale	17.38	45,060	782,972	0	Aug 13 04:02 PM
Daniell Richard	Officer	Aug 12 '24	Proposed Sale	17.30	98,943	1,711,444		Aug 12 04:09 PM
Hughes Eric A	Officer	Aug 09 '24	Proposed Sale	17.38	45,060	782,974		Aug 12 03:59 PM
Grant Angus	Officer	Aug 09 '24	Proposed Sale	17.28	4,065	70,243		Aug 09 03:59 PM
Hughes Eric A	See "Remarks"	Aug 01 '24	Sale	17.25	24,537	423,280	45,060	Aug 05 07:35 AM
Hughes Eric A	Officer	Aug 01 '24	Proposed Sale	17.25	24,537	423,281		Aug 01 04:00 PM
MIGNONE ROBERTO	Director	Jun 18 '24	Sale	17.03	519,000	8,838,570	981,000	Jun 21 04:05 PM
Weiss Amir	Chief Accounting Officer	May 15 '24	Sale	16.80	15,500	260,417	17,814	May 17 07:41 AM
Weiss Amir	Chief Accounting Officer	May 16 '24	Sale	16.65	12,635	210,377	5,179	May 17 07:41 AM
Conway Vikki L	See "Remarks"	May 13 '24	Sale	16.74	15,219	254,807	0	May 15 08:36 AM
Kalif Eliyahu Sharon	EVP, Chief Financial Officer	Mar 06 '24	Sale	13.52	77,550	1,048,119	203,691	Mar 07 04:27 PM
Daniell Richard	Exec. VP, European Commercial	Mar 05 '24	Sale	13.52	48,629	657,240	69,770	Mar 07 04:20 PM
Conway Vikki L	See "Remarks"	Mar 05 '24	Sale	13.52	1,427	19,286	15,219	Mar 07 04:16 PM
Sabag Mark	EVP, International Markets	Mar 05 '24	Sale	13.52	100,000	1,352,090	382,590	Mar 07 04:12 PM
Conway Vikki L	See "Remarks"	Mar 04 '24	Sale	13.37	3,532	47,234	6,617	Mar 05 04:39 PM
Francis Richard D	President and CEO	Mar 04 '24	Sale	13.34	31,061	414,270	123,295	Mar 05 04:27 PM
Daniell Richard	Exec. VP, European Commercial	Mar 04 '24	Sale	13.34	95,762	1,277,207	69,770	Mar 05 04:21 PM
Hughes Eric A	See "Remarks"	Mar 04 '24	Sale	13.34	8,045	107,299	16,855	Mar 05 04:16 PM
Drape Eric	Executive VP Global Operations	Feb 28 '24	Sale	13.12	9,815	128,734	9,701	Mar 01 06:45 AM
Daniell Richard	Exec. VP, European Commercial	Feb 28 '24	Sale	13.12	20,599	270,176	69,770	Mar 01 06:43 AM
Conway Vikki L	See "Remarks"	Feb 28 '24	Sale	13.12	1,366	17,916	2,928	Mar 01 06:40 AM
Drape Eric	Executive VP Global Operations	Feb 16 '24	Sale	13.05	173,261	2,261,905	1	Feb 21 07:37 AM
Francis Richard D	President and CEO	Feb 15 '24	Sale	13.15	74,530	980,174	87,125	Feb 20 07:42 AM
Weiss Amir	Chief Accounting Officer	Feb 01 '24	Sale	12.37	31,766	392,955	10,676	Feb 05 07:49 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Teva- Pharmaceutical Industries Ltd. ADR

Upgrade your FINVIZ experience